Inventor · disambiguated record
Shulong Wang
Also filed as: WANG SHULONG
8 granted patents·12 citations·filing 2004–2017
78Inventor score
Files withCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD3HANGZHOU MINSHENG PHARM GROUP2WANG SHULONG2XIAO DENGMING1
Top patents by PatentIndex Score
8 records- 0179US10745383B21,3,5-triazine derivative and method of using sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Aug 18, 2020·2 cites·15 claims
- 0270US10570141B2Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 0369US9127655B2Liquid nitrogen pump equipment load testing and experimenting apparatus and testing and experimenting method thereofWANG SHULONG·Filed 2011·Granted Sep 8, 2015·4 cites·8 claims
- 0464US9428508B22,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitorsXIAO DENGMING·Filed 2012·Granted Aug 30, 2016·2 cites·3 claims
- 0555US7435838B2Crystalline citalopram diol intermediate alkaliHANGZHOU MINSHENG PHARM GROUP·Filed 2004·Granted Oct 14, 2008·3 cites·24 claims
- 0640US10155722B2Antitumor compound targeting IDH2 mutation and method of use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Dec 18, 2018·0 cites·20 claims
- 0732US9499530B2Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicamentWANG SHULONG·Filed 2012·Granted Nov 22, 2016·0 cites·18 claims
- 0832US7700584B2Curcumol derivatives, the compositions containing the said derivatives, and the use of the same in the manufacture of medicamentsHANGZHOU MINSHENG PHARM GROUP·Filed 2005·Granted Apr 20, 2010·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →